Showing posts with the label Medical ResearchShow all
FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer After 42% Trial Response Rate
Novartis Heart Drug Trial Failure Raises Questions About Lp(a) Treatments
Retatrutide Beats Ozempic on Weight Loss and Blood Sugar in Phase 3 Diabetes Trial
Merck's Experimental Cancer Drug Extends Survival in Phase 3 Endometrial Cancer Trial
Ebola Vaccine Trial Begins in Congo to Test Protection Against Bundibugyo Virus
New Hepatitis B Study Raises Concerns About US Newborn Vaccine Guidance
Bristol Myers Discloses Patient Death in Experimental CAR-T Multiple Sclerosis Trial
Microsoft AI Outperforms Doctors in Diagnostic Tests, but Real-World Questions Remain
Moderna and Merck's mRNA Melanoma Vaccine Cuts Recurrence Risk 42% in Phase 3 Trial
Load More That is All